Mini ReviewMechanisms of probiotic actions – A review
Introduction
In this review I will give an overview on the effects of probiotics. It has to be taken into account, that many reported mechanisms of probiotic actions are the results of in vitro experiments. Therefore, these results must be confirmed by in vivo studies.
The effects of probiotics may be classified in three modes of action. (i) Probiotics might be able to modulate the host's defences including the innate as well as the acquired immune system. This mode of action is most likely important for the prevention and therapy of infectious diseases but also for the treatment of (chronic) inflammation of the digestive tract or parts thereof. In addition, this probiotic action could be important for the eradication of neoplastic host cells. (ii) Probiotics can also have a direct effect on other microorganisms, commensal and/or pathogenic ones. This principle is in many cases of importance for the prevention and therapy of infections and restoration of the microbial equilibrium in the gut. (iii) Finally, probiotic effects may be based on actions affecting microbial products like toxins, host products e.g. bile salts and food ingredients. Such actions may result in inactivation of toxins and detoxification of host and food components in the gut.
All three modes of probiotic action are in all likelihood involved in infection defence, prevention of cancer and in stabilising or reconstituting the physiological balance between the intestinal microbiota and its host. However, it has to be stressed that there seems not to be one probiotic exhibiting all three principles, at least not to that extent that it could be a remedy for prevention or therapy of all mentioned kinds of disease. It depends on the metabolic properties, the kind of surface molecules expressed and components to be secreted which probiotic actions a certain probiotic strain might show. The era of “omics” we are living in at this time, will make crucial contributions because it enables the analysis and comparison of whole genomes, transcriptomes, proteomes and secretomes (see also Wohlgemuth et al., 2010). This all will lead to the identification and characterisation of probiotic properties, distinguishing real probiotics from those, which are not.
Section snippets
Immune modulation
Probiotics can influence the immune system by products like metabolites, cell wall components and DNA. Obviously, immune modulatory effects might be even achieved with dead probiotic bacteria or just probiotics-derived components like peptidoglycan fragments or DNA. Probiotic products are recognized by host cells sensitive for these because they are e.g. equipped with recognition receptors. The main target cells in that context are therefore gut epithelial and gut-associated immune cells. The
Antimicrobial substances produced by probiotics
Bacteriocins. In vitro-studies showed inhibition of pathogen replication mediated by low-molecular-weight substances. Top of this list are short chain fatty acids e.g. lactic acid. A similar effect was observed for hydrogen peroxide. Also low-molecular-weight bacteriocins (LMWB) and high-molecular-weight bacteriocins (class III) are produced by lactobacilli. The LMBW are antimicrobial peptides. LMWB can be grouped into three classes: (class I) lantibiotics, posttranslationally modified peptides
Designer probiotics
The identification of toxin receptors paved the way for recombinant E. coli expressing receptor structures at their surface identical with the receptor for a certain toxin. Such designer probiotics bind very efficiently e.g. shiga toxin 1 (Stx1) and 2 (Stx2). One mg bacterial dry weight is able to bind more than 100 μg Stx1 or Stx2. This was achieved by replacing the O-side chains of the original LPS by Gb3, the receptor for these toxins. The resulting recombinant strain protected all mice after
Inhibitory activity against genotoxins
There are claims for anti-cancer activity of probiotics. If such a protection occurs in humans who consume the appropriate probiotic is unknown. However, the repression of putrefactive bacteria such as Clostridium, coliforms or Bacteroides species and an increase in numbers of lactobacilli and bifidobacteria might at least reduce the probability of incidence for colorectal cancer. The incidence of adenocarcinoma in the colon of IL-10 knockout mice was factually reduced in mice treated with
Final remarks
Taken into account the low number of probiotic bacteria administered with a daily dose of 109 or 1010 bacteria compared to up to 1014 bacteria in the colon it is to some extent surprising that there are probiotic effects observable at all. Still this minority is able to kill pathogens, inhibit probably adhesion and invasion of pathogens, inactivate toxins and compete for limited resources successfully. This might be explained by colonization of the same gut compartment by probiotics and
References (54)
- et al.
The probiotic Escherichia coli strain Nissle 1917 interferes with invasion of human intestinal epithelial cells by different enteroinvasive bacterial pathogens
FEMS Immunol. Med. Microbiol.
(2004) - et al.
Lactobacillus rhamnosus induces peripheral hyporesponsiveness in stimulated CD4+ T cells via modulation of dentritic cell function
Am. J. Clin. Nutr.
(2004) - et al.
The effect of probiotics and organic acids on shiga-toxin 2 gene expression in enterohemorrhagic Escherichia coli O157:H7
J. Microbiol. Methods
(2008) - et al.
Antimicrobial proteinaceous compounds obtained from bifidobacteria: from production to their application
Int. J. Food Microbiol.
(2008) - et al.
Sacchamromyces boulardii inhibits ERK1/2 mitogen-activated protein kinase activation both in vitro and in vivo and protects against Clostridium difficile toxin A-induced enteritis
J. Biol. Chem.
(2006) - et al.
Protective action of Lactobacillus kefir carrying S-layer protein against Salmonella enterica serovar Enteritidis
Int. J. Food Microbiol.
(2007) - et al.
The role of probiotic bacteria in cancer prevention
Microbes Infect.
(2000) - et al.
Specific strains of probiotic bacteria are efficient in removal of several different cyanobacterial toxins from solution
Toxicon
(2008) - et al.
Probiotics inhibit nuclear factor-κB and induce heat shock proteins in colonic epithelial cells through proteasome inhibition
Gastroenterology
(2004) - et al.
Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis
Gastroenterology
(2004)
The effect of probiotic treatment with Clostridium butyricum on enterohemorrhagic Escherichia coli O157:H7 infection in mice
FEMS Immunol. Med. Microbiol.
Lactobacillus rhamnosus strain GG restores alkaline phosphatase activity in differentiating Caco-2 cells dosed with the potent mycotoxin deoxynivalenol
Food Chem. Toxicol.
Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth
Gastroenterology
Probiotic bifidobacteria protect mice from lethal infection with shiga toxin-producing Escherichia coli O157:H7
Infect. Immun.
Adhesion of the probiotic strains Enterococcus mundtii ST4SA and Lactobacillus plantarum 423 to Caco-2 cells under conditions simulating the intestinal tract, and in the presence of antibiotics and anti-inflammatory medicaments
Arch. Microbiol.
Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum
Infect. Immun.
Probiotic Lactobacillus reuteri promotes TNF-induced apoptosis in human myeloid leukemia-derived cells by modulation of NF-κB and MAPK signalling
Cell. Microbiol.
Glycerol induces reuterin production and decreases Escherichia coli population in an in vitro model of colonic fermentation with immobilized human feces
FEMS Microbiol. Ecol.
Probiotic strains and their combination inhibit in vitro adhesion of pathogens to pig intestinal mucosa
Curr. Microbiol.
Role of commercial probiotic strains against human pathogen adhesion to intestinal mucus
Lett. Appl. Microbiol.
Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118
Proc. Natl. Acad. Sci. USA
Iron requirement of Lactobacillus spp. in completely chemically defined growth media
J. Appl. Microbiol.
Probiotics, prebiotics and synbiotics. A role in chemoprevention of colorectal cancer?
Cancer Biol. Ther.
Enhanced anti-inflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids
Proc. Natl. Acad. Sci. USA
Lactobacillus rhamnosus strain GG modulates intestinal absorption, fecal excretion, and toxicity of aflatoxin B1 in rats
Appl. Environ. Microbiol.
Lactobacillus rhamnosus strain GG reduces aflatoxin B1 transport, metabolism, and toxicity in Caco-2 cells
Appl. Environ. Microbiol.
A new ferrous iron-uptake transporter, EfeuU (YcdN), from Escherichia coli
Mol. Microbiol.
Cited by (517)
Invited review: “Probiotic” approaches to improving dairy production: Reassessing “magic foo-foo dust”
2024, Journal of Dairy ScienceEmerging trends and applications in health-boosting microorganisms-specific strains for enhancing animal health
2023, Microbial Pathogenesis